SQUAMOUS CELL CARCINOMA, HEAD AND NECK
Clinical trials for SQUAMOUS CELL CARCINOMA, HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA, HEAD AND NECK trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA, HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy combo shows promise in reducing head and neck cancer recurrence
Disease control CompletedThis phase 2 trial tested whether adding the immunotherapy drug pembrolizumab (Keytruda) to standard surgery, radiation, and chemotherapy could help prevent head and neck cancer from coming back. The study enrolled 67 adults with advanced, surgically removable head and neck squam…
Matched conditions: SQUAMOUS CELL CARCINOMA, HEAD AND NECK
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Old chemo drug gets new look for tough head and neck cancers
Disease control CompletedThis phase 2 trial tested the chemotherapy drug mitomycin C in 48 patients with incurable head and neck cancer that had stopped responding to standard treatments. The goal was to see if the drug could shrink tumors. Researchers hope to find a new option for patients with very lim…
Matched conditions: SQUAMOUS CELL CARCINOMA, HEAD AND NECK
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC